PubMed for id: 220064

Year	Number of Results
2002	2
2004	1
2006	1
2007	1
2008	1
2009	2
2010	3
2011	3
2012	4
2013	1
2014	2
2015	3
2017	1
2018	1
2020	2
2021	4
2022	1
2024	1

1

ORAOV1-B Promotes OSCC Metastasis via the NF-κB-TNFα Loop.

Luo X, Jiang Y, Chen F, Wei Z, Qiu Y, Xu H, Tian G, Gong W, Yuan Y, Feng H, Zhong L, Ji N, Xu X, Sun C, Li T, Li J, Feng X, Deng P, Zeng X, Zhou M, Zhou Y, Dan H, Jiang L, Chen Q. Luo X, et al. J Dent Res. 2021 Jul;100(8):858-867. doi: 10.1177/0022034521996339. Epub 2021 Mar 3. J Dent Res. 2021. PMID: 33655785

2

Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.

Ha SY, Yeo SY, Lee KW, Kim SH. Ha SY, et al. J Cancer Res Clin Oncol. 2021 Feb;147(2):423-433. doi: 10.1007/s00432-020-03437-x. Epub 2020 Nov 8. J Cancer Res Clin Oncol. 2021. PMID: 33161447

3

ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.

Li M, Cui X, Shen Y, Dong H, Liang W, Chen Y, Hu J, Li S, Kong J, Li H, Zhao J, Li F. Li M, et al. Hum Pathol. 2015 May;46(5):707-15. doi: 10.1016/j.humpath.2015.01.009. Epub 2015 Feb 4. Hum Pathol. 2015. PMID: 25732110

4

ORAOV1 is a probable target within the 11q13.3 amplicon in lymph node metastases from gastric adenocarcinoma.

Kang JU, Koo SH. Kang JU, et al. Int J Mol Med. 2012 Jan;29(1):81-7. doi: 10.3892/ijmm.2011.811. Epub 2011 Oct 11. Int J Mol Med. 2012. PMID: 21993861

5

ORAOV1 is amplified in oral squamous cell carcinoma.

Xavier FC, Rodini CO, Paiva KB, Destro MF, Severino P, Moyses RA; Head and Neck Genome Project GENCAPO; Tajara EH, Nunes FD. Xavier FC, et al. J Oral Pathol Med. 2012 Jan;41(1):54-60. doi: 10.1111/j.1600-0714.2011.01053.x. Epub 2011 May 28. J Oral Pathol Med. 2012. PMID: 21623924

6

Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.

Jiang L, Zeng X, Wang Z, Ji N, Zhou Y, Liu X, Chen Q. Jiang L, et al. Mol Cancer. 2010 Jan 28;9:20. doi: 10.1186/1476-4598-9-20. Mol Cancer. 2010. PMID: 20105337 Free PMC article.

7

ORAOV1-A correlates with poor differentiation in oral cancer.

Jiang L, Yang HS, Wang Z, Zhou Y, Zhou M, Zeng X, Chen QM. Jiang L, et al. J Dent Res. 2009 May;88(5):433-8. doi: 10.1177/0022034509336994. J Dent Res. 2009. PMID: 19493886

8

Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.

Jiang L, Zeng X, Yang H, Wang Z, Shen J, Bai J, Zhang Y, Gao F, Zhou M, Chen Q. Jiang L, et al. Int J Cancer. 2008 Oct 15;123(8):1779-86. doi: 10.1002/ijc.23734. Int J Cancer. 2008. PMID: 18688849 Free article.

9

High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

Huang X, Gollin SM, Raja S, Godfrey TE. Huang X, et al. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11369-74. doi: 10.1073/pnas.172285799. Epub 2002 Aug 9. Proc Natl Acad Sci U S A. 2002. PMID: 12172009 Free PMC article.

10

Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features.

Xia J, Chen Q, Li B, Zeng X. Xia J, et al. Oral Oncol. 2007 May;43(5):508-14. doi: 10.1016/j.oraloncology.2006.05.008. Epub 2006 Sep 26. Oral Oncol. 2007. PMID: 17005439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year